Systemic Adjustments: Brief, mild stomach discomfort or very occasional mild headaches as the bodys metabolic engine accelerates
[14] HA-KPV nanoparticles demonstrated superior mucosal outcomes compared to free KPV in both in vitro and in vivo ulcerative colitis models
Authors contributions JK designed the study, wrote the protocol, collected clinical data, analyzed data, and wrote the initial draft of the paper
Consequently, BPC 157 may have beneficial activity with the same dose range, and same equipotent routes of application, regardless of injury tested (Sikiric et al., 1993
Nerve Regeneration Peripheral nerve injury studies showed: Improved functional recovery Enhanced axonal regeneration Reference: Gwyer et al., 2019 5